Vyjuvek Kit
Product Images NDC 82194-510

23 FDA label images from Krystal Biotech, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Vyjuvek (NDC 82194-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Krystal Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1 2025)

Fig1 (Fig1 2025)
An instructional diagram showing the contents and removal of components from a VYJUVEK kit. The image depicts a box containing two vials labeled 'Vyjuv' and 'Excipient' with an arrow indicating the excipient vial being removed, alongside separate illustrated vials of Vyjuv and excipient outside the box.*
FDA Label Image

Fig2 (Fig2 2025)

Fig2 (Fig2 2025)
Illustration showing three small bottles labeled 'Exc' arranged from left to right with increasing liquid levels at 0, 10, and 20 minutes, representing a progression or change over time.*
FDA Label Image

Fig3 (Fig3 2025)

Fig3 (Fig3 2025)
An instructional diagram showing how to withdraw 1 ml of liquid medication using a syringe from a vial or container. The syringe is positioned at an angle between 45 and 90 degrees from the vial opening, with an upward arrow indicating the direction to pull the plunger.*
FDA Label Image

Fig4 (Fig4 2025)

Fig4 (Fig4 2025)
An instructional diagram showing a syringe being filled from a vial. The syringe is positioned vertically above the vial with an arrow indicating downward motion to draw liquid into the syringe, illustrating the process of medication preparation within the VYJUVEK kit by Krystal Biotech, Inc.*
FDA Label Image

Fig5 (Fig5 2025)

Fig5 (Fig5 2025)
An instructional line drawing illustrating the preparation of an injection using a syringe and a vial. One hand holds the vial upright while the other hand draws fluid into the syringe through the vial's stopper. This image likely shows part of the preparation steps for administering VYJUVEK, a prescription drug kit by Krystal Biotech, Inc.*
FDA Label Image

Fig6 (Fig6 2025)

Fig6 (Fig6 2025)
Instructional line drawing showing a hand holding a syringe drawing liquid from a vial. The syringe contains an air pocket above the liquid. This likely illustrates proper technique for preparing a dose using VYJUVEK, a human prescription drug kit by Krystal Biotech, Inc.*
FDA Label Image

Fig7 (Fig7 2025)

Fig7 (Fig7 2025)
An instructional line drawing showing a hand holding a small vial or container with a removable cap. Arrows indicate the cap should be twisted or turned to open or close the vial. This diagram is likely part of usage or handling instructions for the VYJUVEK kit by Krystal Biotech, Inc.*
FDA Label Image

Fig8 (Fig8 2025)

Fig8 (Fig8 2025)
An illustration showing a syringe attached to an intravenous (IV) set, with the needle inserted into the stopper of a medicine vial below. The syringe is vertically aligned above the vial, demonstrating the preparation or withdrawal of medication from the vial.*
FDA Label Image

Fig9 (Fig9 2025)

Fig9 (Fig9 2025)
An instructional diagram showing a syringe drawing liquid from a vial positioned at a 45-degree angle, with an arrow indicating air pocket movement in the syringe, illustrating proper technique for handling the vial and syringe angle during injection preparation.*
FDA Label Image

Fig10 (Fig10 2025)

Fig10 (Fig10 2025)
An instructional diagram showing how to use a syringe with a vial. The syringe is positioned above the vial with an arrow indicating downward insertion, and the syringe plunger is pulled back to draw liquid, creating an air pocket inside the syringe.*
FDA Label Image

Fig11 (Fig11 2025)

Fig11 (Fig11 2025)
An instructional diagram showing proper handling of a syringe containing air pockets. The left image illustrates holding the syringe vertically with fingers pressing and releasing the plunger, indicating air pocket movement. The right image shows the syringe without visible air pockets, confirmed by a magnified circular inset with a check mark.*
FDA Label Image

Fig12 (Fig12 2025)

Fig12 (Fig12 2025)
An instructional diagram showing a syringe with a cap being removed, illustrating how to prepare the syringe for use. The image depicts a syringe barrel, plunger, and a detachable cap being lifted off the syringe tip.*
FDA Label Image

Fig13 (Fig13 2025)

Fig13 (Fig13 2025)
An instructional illustration showing syringe assembly steps, where a syringe is being attached and locked onto a vial adapter, with arrows indicating the direction for connecting the syringe to the vial.*
FDA Label Image

Fig14 (Fig14 2025)

Fig14 (Fig14 2025)
An instructional illustration showing a syringe injecting a substance into an arm. A magnified inset highlights the injection site with small circular spots and a check mark indicating correctness. The image implies proper technique for administration.*
FDA Label Image

Fig15 (Fig15 2025)

Fig15 (Fig15 2025)
An illustration of a human eye with an arrow indicating the lower eyelid, likely depicting the application site or method related to the drug VYJUVEK.*
FDA Label Image

Fig16 (Fig16 2025)

Fig16 (Fig16 2025)
An instructional diagram showing how to open a packaging seal, depicting a hand peeling back a corner tab from a sealed pouch or container. No text or branding is visible.*
FDA Label Image

Picture1-syringe (Picture1 Syringe)

Picture1-syringe (Picture1 Syringe)
A photo of a transparent plastic syringe with measurement markings in milliliters (mL). The syringe has a white plunger and a lavender-colored cap on the needle end. This syringe is part of the VYJUVEK kit, a human prescription drug by Krystal Biotech, Inc.*
FDA Label Image

Ifu-fig1 (Ifu Fig1)

Ifu-fig1 (Ifu Fig1)
An instructional illustration showing a syringe injecting a liquid into a circular patch with multiple small perforations, placed on the inner forearm of a person's arm. A zoomed inset highlights the needle delivering liquid through the perforations in the patch.*
FDA Label Image

Ifu-fig2 (Ifu Fig2)

Ifu-fig2 (Ifu Fig2)
An instructional illustration showing a fingertip with a small patch of topically applied material highlighted on the skin surface. The image appears to demonstrate the application or placement of the active substance or product on the skin.*
FDA Label Image

Ifu-fig3 (Ifu Fig3)

Ifu-fig3 (Ifu Fig3)
An instructional illustration showing a hand holding a small applicator or pellet above an eye, with an arrow indicating the motion of placing or administering the applicator onto the eye surface. This likely demonstrates the method of application for VYJUVEK, a prescription drug kit by Krystal Biotech, Inc.*
FDA Label Image

Vial 001-01 (Vial00101 2025)

Vial 001-01 (Vial00101 2025)
Label panel for VYJUVEK Excipient Gel, a 1.5 mL human prescription drug kit. The label includes space for lot number and expiration date, states it is Rx only, and identifies Sharp Sterile Manufacturing as the manufacturer.*
FDA Label Image

Vial 501-01 (Vial5101 2025)

Vial 501-01 (Vial5101 2025)
The label for VYJUVEK kit shows the product name VYJUVEK and the active ingredient name beremagene geperpavec-svdt. It includes the NDC number 82194-501-01, a lot number and expiration date in a vertical layout, and indicates the volume as 1 mL. The label states the manufacturer as Krystal Biotech, Inc., and notes the drug is Rx only.*
FDA Label Image

Carton (Carton 2025)

Carton (Carton 2025)
Packaging label for VYJUVEK, a kit by Krystal Biotech, Inc. The carton lists VYJUVEK with a concentration of 5 x 10^7 PFU/mL. The label includes storage instructions, contents of the carton (one 1 mL vial, one 1.5 mL excipient gel), and usage for topical use only. The label shows the NDC code 82194-510-02, manufacturing information, lot and expiration placeholders, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.